Research reading room
Cystic Tumor of the Pancreas (Johns Hopkins, PNAS 2011)
Summary
Cystic Tumor of the Pancreas (Johns Hopkins, PNAS 2011) is a study catalogued by cBioPortal DataHub under the cancer-type code pact. EvidenceHelix groups it with pancreas studies.
Study description
Whole-exome sequencing of major neoplastic cyst types of the pancreas: 8 serous cystadenomas (SCAs), 8 intraductal papillary mucinous neoplasms (IPMNs), 8 mucinous cystic neoplasms (MCNs), and 8 solid pseudopapillary neoplasms (SPNs).
Text as published in the source's study metadata.
Citation & PubMed
Wu et al. PNAS 2011
Linked PubMed records: PMID 22158988
Source & licence
Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.
Source metadata
- Study identifier
- pact_jhu_2011
- Short name
- Pancreas (JHU 2011)
- Source cancer-type code
- pact
- Reference genome
- not given
- Source access groups
- PUBLIC
- Original study
- View on cBioPortal
- Metadata file
- meta_study.txt at e1b75cd25b
- Database licence
- ODC Open Database License (ODbL) 1.0
Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.
Citations
Wu et al. PNAS 2011
Citation counts are not part of the source metadata and are not shown.
Related studies
-
Acinar Cell Carcinoma of the Pancreas (JHU, J Pathol 2014)
Whole exome sequencing of 23 surgically resected pancreatic carcinomas with acinar differentiation and their matched normals.
PancreasOther published and consortium studiesSource code paacPubMed 1 -
Metastatic Pancreatic Adenocarcinoma (PRINCE Trial, Nat Med. 2022) - iAtlas Harmonized
Whole-exome sequencing and neoantigen landscape analysis of 93 metastatic pancreatic adenocarcinomas and their matched normals from a randomized phase 2 trial evaluating the efficacy of nivolumab and/or sotigalimab wi…
PancreasOther published and consortium studiesSource code paadPubMed 1 -
Pancreatic Adenocarcinoma (ICGC, Nature 2012)
Whole-exome sequencing of 99 pancreatic samples and their matched normals.
PancreasOther published and consortium studiesSource code paadPubMed 1 -
Pancreatic Adenocarcinoma (QCMG, Nature 2016)
Whole-genome and deep-exome sequencing analysis of 456 pancreatic ductal adenocarcinomas
PancreasOther published and consortium studiesSource code paadPubMed 1 -
Pancreatic Cancer (UTSW, Nat Commun 2015)
Whole exome sequencing of 109 micro-dissected pancreatic cancer cases and normal control tissue.
PancreasOther published and consortium studiesSource code paadPubMed 1 -
Pancreatic Ductal Adenocarcinoma (CPTAC, Cell 2021)
Whole-genome sequencing (WGS) and whole-exome sequencing (WES) of 140 pancreatic cancers with 67 normal adjacent tissues. Proteogenomic characterization generated by CPTAC.
PancreasOther published and consortium studiesSource code paadPubMed 1 -
Pancreatic Neuroendocrine Tumors (Johns Hopkins University, Science 2011)
Whole exome sequencing of 10 pancreatic neuroendocrine tumor patients.
PancreasOther published and consortium studiesSource code panetPubMed 1 -
Pancreatic Neuroendocrine Tumors (Multi-Institute, Nature 2017)
Whole-genome sequencing of 98 pancreatic neuroendocrine tumours (PanNETs) and matched normal DNA pairs.
PancreasOther published and consortium studiesSource code panetPubMed 1